NCT05278637View on ClinicalTrials.gov

GM03 - Platelet RNA Signatures of Aspirin

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

November 1, 2013

Primary Completion Date

December 5, 2016

Study Completion Date

December 5, 2016

Conditions
Platelet Aggregation InhibitorsAspirinTicagrelorRNA
Interventions
DRUG

Aspirin

Aspirin 81mg/day x 4 weeks, Aspirin 325mg/day x 4 weeks. or Aspirin 325mg/day x 4 weeks, Aspirin 81mg/day x 4 weeks.

DRUG

Ticagrelor

Ticagrelor 90mg BID x 4 weeks

Trial Locations (1)

27705

Duke University, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER